statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

REC formed bullish candlestick pattern on the daily charts with above average volumes. The 50-day EMA (exponential moving average placed at Rs 445) is crucial to watch in the coming session.

Trade Spotlight | How to deal in REC, United Spirits, Ajanta Pharma today

Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2515 in its research report dated January 31, 2024.

Buy Ajanta Pharma; target of Rs 2515: Motilal Oswal

Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The firm offers branded generics and generics that serve a range of therapeutic segments such as antibiotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory, and general health. It operates through the following geographical segments: India, Africa, Asia, and USA. The company was founded by Purushottam Bhagwand Agrawal in 1973 and is headquartered in Mumbai, India.

Ajanta Pharma Ltd.

Volume	69,788.00
52-Wk High	2,353.95
52-Wk Low	1,235.89

AJANTPHARM.NSE Ajanta Pharma Ltd.

About

Feed

News

Sentiment

Fundamentals